🇺🇸 FDA
Company

BRIGHT

BRIGHT MINDS BIOSCIENCES INC.

DRUG pharma USA

Quick answer

BRIGHT is a pharma company (DRUG) headquartered in NEW YORK, NY, USA with 24 tracked pipeline programs.

Pipeline (24)

project

10-week smoking cessation group therapy combined with NicoDerm CQ

Tobacco Use Cessation

Phase 3 · other · completed

1 trials project

Active referral

Smoking

Phase 3 · other · active

1 trials project

Acyclovir

HIV Infections

Phase 3 · small_molecule · completed

1 trials project

Adderall-XR

Cannabis Use Disorder

Phase 3 · small_molecule · completed

1 trials project

Agitated Saline SoC

Right-To-Left Shunt

Phase 3 · small_molecule · active

1 trials project

B007

Primary Membranous Nephropathy

Phase 3 · small_molecule · active

2 trials project

B007

Generalized Myasthenia Gravis

Phase 3 · small_molecule · active

1 trials project

B013+Nab-Paclitaxel

Triple Negative Breast Cancer (TNBC)

Phase 3 · small_molecule · completed

1 trials project

Bedaquiline

Multi-drug Resistant Tuberculosis

Phase 3 · small_molecule · active

1 trials project

Behavior Therapy

Substance-Related Disorders

Phase 3 · other · completed

3 trials project

Behavior Therapy

HCV Negative Status

Phase 3 · other · completed

1 trials project

Behavior Therapy

Behavior Therapy

Phase 3 · other · completed

1 trials project

Behavior Therapy

Marijuana Abuse

Phase 3 · other · completed

1 trials project

Behavioral Drug and HIV Risk Reduction Counseling

Opiate Dependence

Phase 3 · other · completed

1 trials project

Bias retraining

Alcohol Use Disorder

Phase 3 · other · completed

1 trials project

Booster Sessions

Skill Development of Staff

Phase 3 · other · completed

1 trials project

Brief Strategic Family Therapy (BSFT)

Substance Abuse

Phase 3 · other · completed

1 trials project

Brief advice

Drug Abuse

Phase 3 · other · completed

1 trials project

Brief motivational intervention

Drug Use

Phase 3 · other · completed

1 trials project

Buprenorphine

Heroin Dependence

Phase 3 · small_molecule · completed

2 trials project

Buprenorphine

Opioid-use Disorder

Phase 3 · small_molecule · active

1 trials project

Buprenorphine

Cocaine-Related Disorders

Phase 3 · small_molecule · completed

5 trials project

Buprenorphine + Naltrexone

Cocaine Dependence

Phase 3 · small_molecule · completed

1 trials project

Buprenorphine +OTP

Heroin Addiction

Phase 3 · small_molecule · completed

1 trials

Drugs (2)

drug

fluticasone propionate

FLUTICASONE PROPIONATE

 drug

fondaparinux sodium

FONDAPARINUX SODIUM

Patents (8)

patent

US 12383631

Immune antigen specific IL-18 immunocytokines and uses thereof

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12350120

Gum-protecting and teeth-whitening strip and preparation method thereof

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12220447

Proteolytic enzyme composition

Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12215133

GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and use

Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12173062

Modified TNF-α antibodies and uses thereof

Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12115136

Fortified CBD oil for treatment of PTSD

Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12097230

Method and composition for treating post operative conditions

Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11925686

Materials for phototherapies of ophthalmic diseases

Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)